Chromatographic resolution of angiotensin II receptor antagonists (sartans)

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 1:1027:57-63. doi: 10.1016/j.jchromb.2016.05.023. Epub 2016 May 17.

Abstract

First time a simple, sensitive and unified quantification method has been developed to analyze the complete class of angiotensin II receptor antagonists which are used in the treatment of hypertension either alone or in combination with some other drugs. The most important advantage of developed method was that the eight separate drugs can be determined on a single chromatographic system without modifications in detection wavelength and mobile phase. The drugs were separated on a Purospher Star 4.6mm×25cm, 5μm, C18 column maintained at 40°C with 1mLmin(-1) flow rate using ultra violet detection at 254nm. Good separation (Rs>2.0) was achieved in a short analysis allowing simultaneous determination of all eight sartans. The effect of variation in flow rate, detection wavelength and column oven temperature was also studied. The proposed method was statistically validated in terms of precision, accuracy, linearity, specificity and robustness. The newly developed method proved to be specific, robust and accurate for the quantification of eight sartans in commercial pharmaceutical formulations.

Keywords: Drug analogues; HPLC; Sartans; Unified quantification; Validation.

Publication types

  • Validation Study

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / analysis*
  • Angiotensin II Type 1 Receptor Blockers / isolation & purification
  • Chromatography, High Pressure Liquid / methods*
  • Limit of Detection
  • Linear Models
  • Reproducibility of Results
  • Tablets

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Tablets